4:30PM Leveraging Immunogenicity Insights & Companion Diagnostics to Predict Risks & Enhance Gene Therapy Safety
Time: 4:30 pm
day: Conference Day 1
Details:
• Understanding how transgene immunogenicity impacts patient safety and therapy outcomes
• Leveraging advanced diagnostics to predict and mitigate safety risks
• Reviewing current assays, modalities, and tools designed to address safety concerns in the patient
